New England Biolabs Offers Development Tools for a New Generation of Laboratory Tests
New England Biolabs is improving accessibility with a range of development tools, including shelf-stable reagents and enzyme-based tools.
Read MorePosted by Chris Wolski | Oct 30, 2024 | Immunoassay |
New England Biolabs is improving accessibility with a range of development tools, including shelf-stable reagents and enzyme-based tools.
Read MorePosted by Andy Lundin | Oct 16, 2024 | Cardiovascular |
A new blood test can diagnose heart attacks in just 5-7 minutes, with potential applications for both clinical settings and at-home use.
Read MorePosted by Chris Wolski | Oct 10, 2024 | Sequencing Systems |
Reducing the incidence of healthcare-associated infections, and the antimicrobial resistance they can trigger, is critical for patient care.
Read MorePosted by Andy Lundin | Oct 9, 2024 | Molecular Diagnostics |
Delve Bio partnered with Broad Clinical Labs to accelerate commercialization and accessibility of mNGS for diagnosing neurological infection.
Read MorePosted by Andy Lundin | Sep 30, 2024 | Molecular Diagnostic Analyzers |
The digital PCR system brings precise DNA and RNA quantification to diagnostics for applications like cancer monitoring and liquid biopsies.
Read More